Thomas M. File
File, Thomas
File, Thomas M.
File, Thomas M., Jr
VIAF ID: 315218985 (Personal)
Permalink: http://viaf.org/viaf/315218985
Preferred Forms
- 100 1 _ ‡a File, Thomas
-
-
-
-
-
- 100 1 _ ‡a File, Thomas M.
- 100 1 _ ‡a File, Thomas M. ‡c Jr
-
- 100 0 _ ‡a Thomas M. File
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Community-acquired respiratory infections : antimicrobial management | |
Emerging and resistant pathogens in respiratory tract infections, c1997: | |
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients | |
Necrotic Skin Lesions Associated With Disseminated Candidiasis | |
New diagnostic tests for pneumonia: what is their role in clinical practice? | |
A new dosing paradigm: high-dose, short-course fluoroquinolone therapy for community-acquired pneumonia | |
New insights in the treatment by levofloxacin | |
Nosocomial (Health Care-Associated) Legionnaire's Disease | |
Optimizing therapy for community-acquired pneumonia with the goal of rapid resolution of illness. | |
An outbreak of Pseudomonas aeruginosa ventilator-associated respiratory infections due to contaminated food coloring dye--further evidence of the significance of gastric colonization preceding nosocomial pneumonia. | |
Overview of resistance in the 1990s | |
Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection | |
Pathways to Leadership: Reflections of Recent Infectious Diseases Society of America (IDSA) Leaders During Conception and Launch of the Inclusion, Diversity, Access, and Equity Movement Within the IDSA | |
The pattern of gram-negative-rod bacteremia in a community hospital | |
Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremia. | |
Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration | |
Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels | |
Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia | |
Pneumococcal vaccine: a different perspective. | |
Pneumonia and empyema caused by Clostridium sordellii | |
Pneumonia in older adults: reversing the trend. | |
Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study | |
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011 | |
Prevention of bloodstream infections: basics and beyond | |
Radiographic appearance of Chlamydia pneumoniae | |
The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group. | |
Rational use of antibiotics to treat respiratory tract infections | |
Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines | |
Recurrent Cellulitis After Bypass Surgery Associated With Psoriasis | |
Reduction of Clostridium difficile Infection in a Community Teaching Hospital Associated with Antimicrobial Stewardship Team Interventions on Fluoroquinolone Utilization. | |
Repeat antimicrobial susceptibility testing of identical isolates | |
Reply to Collins et al. and to Singh | |
Reply to Tang and Lai | |
Reporting and publishing guidelines: article 12 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report | |
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections | |
Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease Group | |
The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections | |
Safety of intravenous infusion of doripenem. | |
SARS | |
SARS : najnowsza ujawniona choroba zakaźna | |
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. | |
Severe acute respiratory syndrome: pertinent clinical characteristics and therapy | |
Shorter course therapy of serious respiratory infections: new data for new approaches to management. | |
SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia. | |
Solutions to the problem of bacterial resistance. | |
Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers | |
Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs. | |
Summary of ceftaroline fosamil clinical trial studies and clinical safety | |
Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe | |
Telithromycin new product overview | |
Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections | |
Treatment of Bacteriuria in Pregnancy | |
Treatment of skin and soft-tissue infections. | |
Update of Legionella infections. | |
Urinary tract infections in the elderly | |
The use of oral fluoroquinolones in nursing home patients | |
Value of noninvasive studies in community-acquired pneumonia | |
Ventilator-associated pneumonia: gearing towards shorter-course therapy | |
What can we learn from the time course of untreated and partially treated community-onset Streptococcus pneumoniae pneumonia? A clinical perspective on superiority and noninferiority trial designs for mild community-acquired pneumonia | |
What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia? | |
Yield, clinical significance, and cost of a combination BACTEC plus Septi-Chek blood culture system | |
প্রত্যুত্তর |